metricas
covid
Gastroenterología y Hepatología (English Edition) SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel d...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
Aceptación de la vacuna frente a SARS-CoV-2 entre gastroenterólogos y pacientes con enfermedad inflamatoria intestinal: proyecto VACUNEII
Rocío Ferreiro-Iglesiasa,b,1,
Corresponding author
rocioferstg@hotmail.com

Corresponding author.
, Alejandro Hernández-Cambac,1, Ruth Serrano Labajosd, Iago Rodríguez-Lagoe,f, Yamile Zabanag,h, Manuel Barreiro-de Acostaa,b, on behalf of Young Group of Geteccu, ACCU Spain
a Gastroenterology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
b Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
c Gastroenterology Department, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain
d The Spanish Confederation of Crohn's & Colitis Associations (ACCU Spain), Madrid, Spain
e Gastroenterology Department, Hospital de Galdakao, Galdakao, Spain
f Biocruces Bizkaia Health Research Institute, Galdakao, Spain
g Gastroenterology Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain
h Center for Biomedical Research and Network in Liver and Digestive Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain
Read
548
Times
was read the article
119
Total PDF
429
Total HTML
Share statistics
Article information
ISSN: 24443824
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 7 3 10
2025 11 42 42 84
2025 10 26 9 35
2025 9 26 15 41
2025 8 22 24 46
2025 7 40 10 50
2025 6 19 0 19
2025 5 24 3 27
2025 4 13 3 16
2025 3 32 4 36
2025 2 65 4 69
2025 1 60 0 60
2024 12 21 2 23
2024 11 3 0 3
2024 10 2 0 2
2024 9 7 0 7
2024 8 1 0 1
2024 7 6 0 6
2024 6 2 0 2
2024 5 2 0 2
2024 4 3 0 3
2024 3 1 0 1
2024 2 2 0 2
2024 1 1 0 1
2023 12 2 0 2
Show all

Follow this link to access the full text of the article